The role of myo-inositol supplement in assisted reproductive techniques

References

• Abdolsamadi, M., Mohammadi, F., Nashtaei, M. S., Teimouri, M., Sardar, R., Dayani, M., Haghighi, M., Ghasemi, S., Vatannejad, A., & Zandieh, Z. (2020). Does myoinositol supplement improve sperm parameters and DNA integrity in patients with oligoasthenoteratozoospermia after the freezing-thawing process? Cell and Tissue Banking, 21(1), 99–106. https://doi.org/10.1007/s10561-019-09801-7
   PubMed Web of Science ®Google Scholar
• Agarwal, A., Makker, K., & Sharma, R. (2008). Clinical relevance of oxidative stress in male factor infertility: An update. American Journal of Reproductive Immunology, 59(1), 2–11. https://doi.org/10.1111/j.1600-0897.2007.00559.x
   PubMed Web of Science ®Google Scholar
• Agarwal, A., Prabakaran, S. A., & Said, T. M. (2005). Prevention of oxidative stress injury to sperm. Journal of Andrology, 26(6), 654–660. https://doi.org/10.2164/jandrol.05016
   PubMedGoogle Scholar
• Akbari Sene, A., Tabatabaie, A., Nikniaz, H., Alizadeh, A., Sheibani, K., Mortezapour Alisaraie, M., Tabatabaie, M., Ashrafi, M., & Amjadi, F. (2019). The myo-inositol effect on the oocyte quality and fertilization rate among women with polycystic ovary syndrome undergoing assisted reproductive technology cycles: A randomized clinical trial. Archives of Gynecology and Obstetrics, 299(6), 1701–1707. https://doi.org/10.1007/s00404-019-05111-1
   PubMed Web of Science ®Google Scholar
• Antony, P. J., Gandhi, G. R., Stalin, A., Balakrishna, K., Toppo, E., Sivasankaran, K., Ignacimuthu, S., & Al-Dhabi, N. A. (2017). Myoinositol ameliorates high-fat diet and streptozotocin-induced diabetes in rats through promoting insulin receptor signaling. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 88, 1098–1113. https://doi.org/10.1016/j.biopha.2017.01.170
   PubMed Web of Science ®Google Scholar
• Avazeri, N., Courtot, A.-M., Pesty, A., Duquenne, C., & Lefevre, B. (2000). Cytoplasmic and nuclear phospholipase C-beta 1 relocation: Role in resumption of meiosis in the mouse oocyte. Molecular Biology of the Cell, 11(12), 4369–4380. https://doi.org/10.1091/mbc.11.12.4369
   PubMed Web of Science ®Google Scholar
• Bar-Oz, B., Koren, G., Nguyen, P., & Kapur, B. M. (2008). Folate fortification and supplementation-are we there yet? Reproductive Toxicology, 25(4), 408–412. https://doi.org/10.1016/j.reprotox.2008.04.010
   PubMed Web of Science ®Google Scholar
• Battaglia, C., Mancini, F., Persico, N., Zaccaria, V., & de Aloysio, D. (2004). Ultrasound evaluation of PCO, PCOS and OHSS. Reproductive Biomedicine Online, 9(6), 614–619. https://doi.org/10.1016/S1472-6483(10)61770-1
   PubMed Web of Science ®Google Scholar
• Beemster, P., Groenen, P., & Steegers-Theunissen, R. (2002). Involvement of inositol in reproduction. Nutrition Reviews, 60(3), 80–87. https://doi.org/10.1301/00296640260042748
   PubMed Web of Science ®Google Scholar
• Benelli, E., Del Ghianda, S., Di Cosmo, C., & Tonacchera, M. (2016). A combined therapy with myo-inositol and D-chiro-inositol improves endocrine parameters and insulin resistance in PCOS young overweight women. International Journal of Endocrinology, 2016, 3204083. https://doi.org/10.1155/2016/3204083
   PubMed Web of Science ®Google Scholar
• Berridge, M. J., & Irvine, R. F. (1984). Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature, 312(5992), 315–321. https://doi.org/10.1038/312315a0
   PubMed Web of Science ®Google Scholar
• Best, M. D., Zhang, H., & Prestwich, G. D. (2010). Inositol polyphosphates, diphosphoinositol polyphosphates and phosphatidylinositol polyphosphate lipids: Structure, synthesis, and development of probes for studying biological activity. Natural Product Reports, 27(10), 1403–1430. https://doi.org/10.1039/b923844c
   PubMed Web of Science ®Google Scholar
• Bevilacqua, A., Carlomagno, G., Gerli, S., Montanino Oliva, M., Devroey, P., Lanzone, A., Soulange, C., Facchinetti, F., Carlo Di Renzo, G., Bizzarri, M., Hod, M., Cavalli, P., D’Anna, R., Benvenga, S., Chiu, T. T., & Kamenov, Z. A. (2015). Results from the international consensus conference on myo-inositol and D-chiro-inositol in obstetrics and gynecology-assisted reproduction technology. Gynecological Endocrinology, 31(6), 441–446. https://doi.org/10.3109/09513590.2015.1006616
   PubMed Web of Science ®Google Scholar
• Beygi, Z., Forouhari, S., Mahmoudi, E., Hayat, S., & Nourimand, F. (2021). Role of oxidative stress and antioxidant supplementation in male fertility. Current Molecular Medicine, 21(4), 265–282. https://doi.org/10.2174/1566524020999200831123553
   PubMed Web of Science ®Google Scholar
• Bizzarri, M., & Carlomagno, G. (2014). Inositol: History of an effective therapy for polycystic ovary syndrome. European Review for Medical and Pharmacological Sciences, 18(13), 1896–1903. https://www.europeanreview.org/article/7565
   PubMed Web of Science ®Google Scholar
• Calogero, A., Gullo, G., La Vignera, S., Condorelli, R., & Vaiarelli, A. (2015). Myoinositol improves sperm parameters and serum reproductive hormones in patients with idiopathic infertility: A prospective double-blind randomized placebo-controlled study. Andrology, 3(3), 491–495. https://doi.org/10.1111/andr.12025
   PubMed Web of Science ®Google Scholar
• Canepa, P., Dal Lago, A., De Leo, C., Gallo, M., Rizzo, C., Licata, E., Anserini, P., Rago, R., & Scaruffi, P. (2018). Combined treatment with myo-inositol, alpha-lipoic acid, folic acid and vitamins significantly improves sperm parameters of sub-fertile men: A multi-centric study. European Review for Medical and Pharmacological Sciences, 22, 7078–7085 https://doi.org/10.26355/eurrev_201810_16180
   PubMed Web of Science ®Google Scholar
• Carlomagno, G., Nordio, M., Chiu, T., & Unfer, V. (2011). Contribution of myo-inositol and melatonin to human reproduction. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 159(2), 267–272. https://doi.org/10.1016/j.ejogrb.2011.07.038
   PubMed Web of Science ®Google Scholar
• Cavalli, P., Tedoldi, S., & Riboli, B. (2008). Inositol supplementation in pregnancies at risk of apparently folate-resistant NTDs. Birth Defects Research. Part A, Clinical and Molecular Teratology, 82(7), 540–542. https://doi.org/10.1002/bdra.20454
   PubMed Web of Science ®Google Scholar
• Chau, J. F., Lee, M., Law, J. W., Chung, S. K., & Chung, S. S. (2005). Sodium/myo-inositol cotransporter-1 is essential for the development and function of the peripheral nerves . FASEB Journal, 19(13), 1887–1889. https://doi.org/10.1096/fj.05-4192fje
   PubMed Web of Science ®Google Scholar
• Chauvin, T. R., & Griswold, M. D. (2004). Characterization of the expression and regulation of genes necessary for myo-inositol biosynthesis and transport in the seminiferous epithelium. Biology of Reproduction, 70(3), 744–751. https://doi.org/10.1095/biolreprod.103.022731
   PubMed Web of Science ®Google Scholar
• Chiu, T. T., Rogers, M. S., Law, E. L., Briton-Jones, C. M., Cheung, L., & Haines, C. J. (2002). Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: Relationship with oocyte quality. Human Reproduction, 17(6), 1591–1596. https://doi.org/10.1093/humrep/17.6.1591
   PubMed Web of Science ®Google Scholar
• Chiu, T. T., & Tam, P. P. (1992). A correlation of the outcome of clinical in vitro fertilization with the inositol content and embryotrophic properties of human serum. Journal of Assisted Reproduction and Genetics, 9(6), 524–530. https://doi.org/10.1007/BF01204248
   PubMed Web of Science ®Google Scholar
• Chiu, T. T. Y., Rogers, M. S., Briton‐Jones, C., & Haines, C. (2003). Effects of myo‐inositol on the in‐vitro maturation and subsequent development of mouse oocytes. Human Reproduction, 18(2), 408–416. https://doi.org/10.1093/humrep/deg113
   PubMed Web of Science ®Google Scholar
• Colazingari, S., Fiorenza, M. T., Carlomagno, G., Najjar, R., & Bevilacqua, A. (2014). Improvement of mouse embryo quality by myo-inositol supplementation of IVF media. Journal of Assisted Reproduction and Genetics, 31(4), 463–469. https://doi.org/10.1007/s10815-014-0188-1
   PubMed Web of Science ®Google Scholar
• Colazingari, S., Treglia, M., Najjar, R., & Bevilacqua, A. (2013). The combined therapy myo-inositol plus D-chiro-inositol, rather than D-chiro-inositol, is able to improve IVF outcomes: Results from a randomized controlled trial. Archives of Gynecology and Obstetrics, 288(6), 1405–1411. https://doi.org/10.1007/s00404-013-2855-3
   PubMed Web of Science ®Google Scholar
• Condorelli, R., La Vignera, S., Di Bari, F., Unfer, V., & Calogero, A. (2011). Effects of myoinositol on sperm mitochondrial function in-vitro. European Review for Medical and Pharmacological Sciences, 15(2), 129–134.
   PubMed Web of Science ®Google Scholar
• Condorelli, R., La Vignera, S., Mongioì, L., Vitale, S., Laganà, A., Cimino, L., & Calogero, A. (2017). Myo-inositol as a male fertility molecule: Speed them up. European Review for Medical and Pharmacological Sciences, 21(2 Suppl), 30–35. https://www.europeanreview.org/article/12993
   PubMedGoogle Scholar
• Condorelli, R. A., La Vignera, S., Bellanca, S., Vicari, E., & Calogero, A. E. (2012). Myoinositol: Does it improve sperm mitochondrial function and sperm motility? Urology, 79(6), 1290–1295. https://doi.org/10.1016/j.urology.2012.03.005
   PubMed Web of Science ®Google Scholar
• Costantino, D., Minozzi, G., Minozzi, E., & Guaraldi, C. (2009). Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: A double-blind trial. European Review for Medical and Pharmacological Sciences, 13(2), 105–110. https://www.europeanreview.org/article/604
   PubMed Web of Science ®Google Scholar
• D’Anna, R., Di Benedetto, V., Rizzo, P., Raffone, E., Interdonato, M. L., Corrado, F., & Di Benedetto, A. (2012). Myo-inositol may prevent gestational diabetes in PCOS women. Gynecological Endocrinology, 28(6), 440–442. https://doi.org/10.3109/09513590.2011.633665
   PubMed Web of Science ®Google Scholar
• Di Paolo, G., & De Camilli, P. (2006). Phosphoinositides in cell regulation and membrane dynamics. Nature, 443(7112), 651–657. https://doi.org/10.1038/nature05185
   PubMed Web of Science ®Google Scholar
• Di Renzo, G., Anceschi, M., & Cosmi, E. (1989). Lung surfactant enhancement in utero. European Journal of Obstetrics & Gynecology and Reproductive Biology, 32(1), 1–11. https://doi.org/10.1016/0028-2243(89)90115-9
   PubMed Web of Science ®Google Scholar
• Dinkova, A., Martinov, D., & Konova, E. (2017). Efficacy of myo-inositol in the clinical management of patients with asthenozoospermia. European Review for Medical and Pharmacological Sciences, 21(2 Suppl), 62–65. https://www.europeanreview.org/article/12302
   PubMedGoogle Scholar
• Downes, C. P., & Macphee, C. H. (1990). Myo-inositol metabolites as cellular signals. European Journal of Biochemistry, 193(1), 1–18. https://doi.org/10.1111/j.1432-1033.1990.tb19297.x
   PubMedGoogle Scholar
• Dutta, S., Majzoub, A., & Agarwal, A. (2019). Oxidative stress and sperm function: A systematic review on evaluation and management. Arab Journal of Urology, 17(2), 87–97. https://doi.org/10.1080/2090598X.2019.1599624
   PubMed Web of Science ®Google Scholar
• Ertzeid, G., & Storeng, R. (2001). The impact of ovarian stimulation on implantation and fetal development in mice. Human Reproduction, 16(2), 221–225. https://doi.org/10.1093/humrep/16.2.221
   PubMed Web of Science ®Google Scholar
• Facchinetti, F., Bizzarri, M., Benvenga, S., D’Anna, R., Lanzone, A., Soulage, C., Di Renzo, G. C., Hod, M., Cavalli, P., Chiu, T. T., Kamenov, Z. A., Bevilacqua, A., Carlomagno, G., Gerli, S., Oliva, M. M., & Devroey, P. (2015). Results from the international consensus conference on myo-inositol and D-chiro-inositol in obstetrics and gynecology: The link between metabolic syndrome and PCOS. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 195, 72–76. https://doi.org/10.1016/j.ejogrb.2015.09.024
   PubMed Web of Science ®Google Scholar
• Facchinetti, F., Espinola, M., Dewailly, D., Ozay, A. C., Prapas, N., Vazquez-Levin, M., Wdowiak, A., & Unfer, V. (2020). Breakthroughs in the use of inositols for assisted reproductive treatment (ART). Trends in Endocrinology and Metabolism: TEM, 31(8), 570–579. https://doi.org/10.1016/j.tem.2020.04.003
   PubMed Web of Science ®Google Scholar
• Fiorenza, M., Torcia, S., Canterini, S., Bevilacqua, A., Narducci, M., Ragone, G., Croce, C. M., Russo, G., & Mangia, F. (2008). TCL1 promotes blastomere proliferation through nuclear transfer, but not direct phosphorylation, of AKT/PKB in early mouse embryos. Cell Death and Differentiation, 15(2), 420–422. https://doi.org/10.1038/sj.cdd.4402228
   PubMed Web of Science ®Google Scholar
• Gardner, D. K., Reed, L., Linck, D., Sheehan, C., & Lane, M. (2005). Quality control in human in vitro fertilization. Seminars in Reproductive Medicine, 23(4), 319–324. https://doi.org/10.1055/s-2005-923389
   PubMed Web of Science ®Google Scholar
• Gerli, S., Papaleo, E., Ferrari, A., & Di Renzo, G. (2007). Randomized, double blind placebo-controlled trial: Effects of myo-inositol on ovarian function and metabolic factors in women with PCOS. European Review for Medical and Pharmacological Sciences, 11(5), 347–354. https://www.europeanreview.org/article/458
   PubMed Web of Science ®Google Scholar
• Ghasemi, A., Amjadi, F., Masoumeh Ghazi Mirsaeed, S., Mohammad Beigi, R., Ghasemi, S., Moradi, Y., & Tahereh Ghazi Mirsaeed, S. (2019). The effect of myo-inositol on sperm parameters and pregnancy rate in oligoasthenospermic men treated with IUI: A randomized clinical trial. International Journal of Reproductive Biomedicine, 17(10), 749–756. https://doi.org/10.18502/ijrm.v17i10.5296
   PubMed Web of Science ®Google Scholar
• Giordano, D., Corrado, F., Santamaria, A., Quattrone, S., Pintaudi, B., Di Benedetto, A., & D’Anna, R. (2011). Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: A perspective, randomized, placebo-controlled study. Menopause, 18(1), 102–104. https://doi.org/10.1097/gme.0b013e3181e8e1b1
   PubMed Web of Science ®Google Scholar
• Goud, P. T., Goud, A. P., Leybaert, L., Oostveldt, P. V., Mikoshiba, K., Diamond, M. P., & Dhont, M. (2002). Inositol 1,4,5-trisphosphate receptor function in human oocytes: Calcium responses and oocyte activation-related phenomena induced by photolytic release of InsP(3) are blocked by a specific antibody to the type I receptor. Molecular Human Reproduction, 8(10), 912–918. https://doi.org/10.1093/molehr/8.10.912
   PubMed Web of Science ®Google Scholar
• Governini, L., Ponchia, R., Artini, P. G., Casarosa, E., Marzi, I., Capaldo, A., Luddi, A., & Piomboni, P. (2020). Respiratory mitochondrial efficiency and DNA oxidation in human sperm after in vitro myo-inositol treatment. Journal of Clinical Medicine, 9(6), 1638. https://doi.org/10.3390/jcm9061638
   PubMed Web of Science ®Google Scholar
• Gulino, F. A., Leonardi, E., Marilli, I., Musmeci, G., Vitale, S. G., Leanza, V., & Palumbo, M. A. (2016). Effect of treatment with myo-inositol on semen parameters of patients undergoing an IVF cycle: In vivo study. Gynecological Endocrinology, 32(1), 65–68. https://doi.org/10.3109/09513590.2015.1080680
   PubMed Web of Science ®Google Scholar
• Hallman, M., Feldman, B. H., Kirkpatrick, E., & Gluck, L. (1977). Absence of phosphatidylglycerol (PG) in respiratory distress syndrome in the newborn. Study of the minor surfactant phospholipids in newborns. Pediatric Research, 11(6), 714–720. https://doi.org/10.1203/00006450-197706000-00003
   PubMed Web of Science ®Google Scholar
• Heimark, D., McAllister, J., & Larner, J. (2014). Decreased myo-inositol to chiro-inositol (M/C) ratios and increased M/C epimerase activity in PCOS theca cells demonstrate increased insulin sensitivity compared to controls. Endocrine Journal, 61(2), 111–117. https://doi.org/10.1507/endocrj.ej13-0423
   PubMed Web of Science ®Google Scholar
• Higgins, B., & Kane, M. (2003). Inositol transport in mouse oocytes and preimplantation embryos: Effects of mouse strain, embryo stage, sodium and the hexose transport inhibitor, phloridzin. Reproduction, 125(1), 111–118. https://doi.org/10.1530/rep.0.1250111
   PubMed Web of Science ®Google Scholar
• Ho, H.-C., & Suarez, S. S. (2003). Characterization of the intracellular calcium store at the base of the sperm flagellum that regulates hyperactivated motility. Biology of Reproduction, 68(5), 1590–1596. https://doi.org/10.1095/biolreprod.102.011320
   PubMed Web of Science ®Google Scholar
• Homa, S. T. (1991). Neomycin, an inhibitor of phosphoinositide hydrolysis, inhibits the resumption of bovine oocyte spontaneous meiotic maturation. The Journal of Experimental Zoology, 258(1), 95–103. https://doi.org/10.1002/jez.1402580111
   PubMedGoogle Scholar
• Homburg, R. (1996). Polycystic ovary syndrome – From gynaecological curiosity to multisystem endocrinopathy. Human Reproduction, 11(1), 29–39. https://doi.org/10.1093/oxfordjournals.humrep.a019031
   PubMed Web of Science ®Google Scholar
• Hourvitz, A., Machtinger, R., Maman, E., Baum, M., Dor, J., & Levron, J. (2009). Assisted reproduction in women over 40 years of age: How old is too old? Reproductive BioMedicine Online, 19(4), 599–603. https://doi.org/10.1016/j.rbmo.2009.04.002
   PubMed Web of Science ®Google Scholar
• Huang, L., Fonteles, M., Houston, D., Zhang, C., & Larner, J. (1993). Chiroinositol deficiency and insulin resistance. III. Acute glycogenic and hypoglycemic effects of two inositol phosphoglycan insulin mediators in normal and streptozotocin-diabetic rats in vivo. Endocrinology, 132(2), 652–657. https://doi.org/10.1210/endo.132.2.8425485
   PubMed Web of Science ®Google Scholar
• Indyk, H. E., & Woollard, D. C. (1994). Determination of free myo-inositol in milk and infant formula by high-performance liquid chromatography. The Analyst, 119(3), 397–402. https://doi.org/10.1039/an9941900397
   PubMed Web of Science ®Google Scholar
• Jenkins, K. J., Correa, A., Feinstein, J. A., Botto, L., Britt, A. E., Daniels, S. R., Elixson, M., Warnes, C. A., & Webb, C. L. (2007). Noninherited risk factors and congenital cardiovascular defects: Current knowledge: A scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: Endorsed by the American Academy of Pediatrics. Circulation, 115(23), 2995–3014. https://doi.org/10.1161/CIRCULATIONAHA.106.183216
   PubMed Web of Science ®Google Scholar
• Jesch, S. A., Zhao, X., Wells, M. T., & Henry, S. A. (2005). Genome-wide analysis reveals inositol, not choline, as the major effector of Ino2p-Ino4p and unfolded protein response target gene expression in yeast. The Journal of Biological Chemistry, 280(10), 9106–9118. https://doi.org/10.1074/jbc.M411770200
   PubMed Web of Science ®Google Scholar
• Kamenov, Z., Kolarov, G., Gateva, A., Carlomagno, G., & Genazzani, A. D. (2015). Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance. Gynecological Endocrinology, 31(2), 131–135. https://doi.org/10.3109/09513590.2014.964640
   PubMed Web of Science ®Google Scholar
• Kane, M. T., & Bavister, B. D. (1988). Vitamin requirements for development of eight-cell hamster embryos to hatching blastocysts in vitro. Biology of Reproduction, 39(5), 1137–1143. https://doi.org/10.1095/biolreprod39.5.1137
   PubMed Web of Science ®Google Scholar
• Kaneko, T., & Ohno, R. (2011). Improvement in the development of oocytes from C57BL/6 mice after sperm injection. Journal of the American Association for Laboratory Animal Science, 50(1), 33–36. https://www.ingentaconnect.com/contentone/aalas/jaalas/2011/00000050/00000001/art00005;jsessionid=1o0m0r4unuoik.x-ic-live-01
   PubMed Web of Science ®Google Scholar
• Khosla, S., Dean, W., Reik, W., & Feil, R. (2001). Culture of preimplantation embryos and its long-term effects on gene expression and phenotype. Human Reproduction Update, 7(4), 419–427. https://doi.org/10.1093/humupd/7.4.419
   PubMed Web of Science ®Google Scholar
• Korosi, T., Barta, C., Rokob, K., & Torok, T. (2017). Physiological Intra-Cytoplasmic Sperm Injection (PICSI) outcomes after oral pretreatment and semen incubation with myo-inositol in oligoasthenoteratozoospermic men: Results from a prospective, randomized controlled trial. European Review for Medical and Pharmacological Sciences, 21(2 Suppl), 66–72. https://www.europeanreview.org/article/12301
   PubMedGoogle Scholar
• Kuşcu, N., Bizzarri, M., & Bevilacqua, A. (2016). Myo-inositol safety in pregnancy: From preimplantation development to newborn animals. International Journal of Endocrinology, 2016, 2413857. https://doi.org/10.1155/2016/2413857
   PubMed Web of Science ®Google Scholar
• Kwon, H. M., Yamauchi, A., Uchida, S., Preston, A., Garcia-Perez, A., Burg, M., & Handler, J. (1992). Cloning of the cDNa for a Na+/myo-inositol cotransporter, a hypertonicity stress protein. Journal of Biological Chemistry, 267(9), 6297–6301. https://doi.org/10.1016/S0021-9258(18)42695-6
   PubMed Web of Science ®Google Scholar
• Laganà, A. S., Vitagliano, A., Noventa, M., Ambrosini, G., & D’Anna, R. (2018). Myo-inositol supplementation reduces the amount of gonadotropins and length of ovarian stimulation in women undergoing IVF: A systematic review and meta-analysis of randomized controlled trials. Archives of Gynecology and Obstetrics, 298(4), 675–684. https://doi.org/10.1007/s00404-018-4861-y
   PubMed Web of Science ®Google Scholar
• Lane, M., & Gardner, D. K. (2007). Embryo culture medium: Which is the best? Best Practice & Research. Clinical Obstetrics & Gynaecology, 21(1), 83–100. https://doi.org/10.1016/j.bpobgyn.2006.09.009
   PubMed Web of Science ®Google Scholar
• Lesoine, B., & Regidor, P.-A. (2016). Prospective randomized study on the influence of myoinositol in PCOS women undergoing IVF in the improvement of oocyte quality, fertilization rate, and embryo quality. International Journal of Endocrinology, 2016, 4378507. https://doi.org/10.1155/2016/4378507
   PubMed Web of Science ®Google Scholar
• Lewin, L. M., Yannai, Y., Melmed, S., & Weiss, M. (1982). Myo-inositol in the reproductive tract of the female rat. The International Journal of Biochemistry, 14(2), 147–150. https://doi.org/10.1016/0020-711X(82)90154-9
   PubMedGoogle Scholar
• Lewin, L. M., Yannai, Y., Sulimovici, S., & Kraicer, P. (1976). Studies on the metabolic role of myo-inositol. Distribution of radioactive myo-inositol in the male rat. The Biochemical Journal, 156(2), 375–380. https://doi.org/10.1042/bj1560375
   PubMed Web of Science ®Google Scholar
• Lim, K. T., Jang, G., Ko, K. H., Lee, W. W., Park, H. J., Kim, J. J., Lee, S. H., Hwang, W. S., Lee, B. C., & Kang, S. K. (2007). Improved in vitro bovine embryo development and increased efficiency in producing viable calves using defined media. Theriogenology, 67(2), 293–302. https://doi.org/10.1016/j.theriogenology.2006.07.011
   PubMed Web of Science ®Google Scholar
• Lisi, F., Carfagna, P., Oliva, M. M., Rago, R., Lisi, R., Poverini, R., Manna, C., Vaquero, E., Caserta, D., Raparelli, V., Marci, R., & Moscarini, M. (2012). Pretreatment with myo-inositol in non polycystic ovary syndrome patients undergoing multiple follicular stimulation for IVF: A pilot study. Reproductive Biology and Endocrinology, 10(1), 52. https://doi.org/10.1186/1477-7827-10-52
   PubMedGoogle Scholar
• Lobo, R. A., & Carmina, E. (2000). The importance of diagnosing the polycystic ovary syndrome. Annals of Internal Medicine, 132(12), 989–993. https://doi.org/10.7326/0003-4819-132-12-200006200-00010
   PubMed Web of Science ®Google Scholar
• Lupo, P. J., Goldmuntz, E., & Mitchell, L. E. (2010). Gene-gene interactions in the folate metabolic pathway and the risk of conotruncal heart defects. Journal of Biomedicine & Biotechnology, 2010, 630940. https://doi.org/10.1155/2010/630940
   PubMedGoogle Scholar
• Martin-Hidalgo, D., Bragado, M. J., Batista, A. R., Oliveira, P. F., & Alves, M. G. (2019). Antioxidants and male fertility: From molecular studies to clinical evidence. Antioxidants, 8(4), 89. https://doi.org/10.3390/antiox8040089
   Web of Science ®Google Scholar
• Mehlmann, L. M., & Kline, D. (1994). Regulation of intracellular calcium in the mouse egg: Calcium release in response to sperm or inositol trisphosphate is enhanced after meiotic maturation. Biology of Reproduction, 51(6), 1088–1098. https://doi.org/10.1095/biolreprod51.6.1088
   PubMed Web of Science ®Google Scholar
• Menichini, D., & Facchinetti, F. (2017). Myoinositol: Mechanisms of action and role in the treatment of metabolic diseases, infertility and polycystic ovary syndrome. Nutrafoods, 16, 147–151. https://www.nutrafoods.eu/index.php/nutra/article/view/83
   Google Scholar
• Michell, R. H. (2008). Inositol derivatives: Evolution and functions. Nature Reviews. Molecular Cell Biology, 9(2), 151–161. https://doi.org/10.1038/nrm2334
   PubMed Web of Science ®Google Scholar
• Milewska, E. M., Czyzyk, A., Meczekalski, B., & Genazzani, A. D. (2016). Inositol and human reproduction. From cellular metabolism to clinical use. Gynecological Endocrinology, 32(9), 690–695. https://doi.org/10.1080/09513590.2016.1188282
   PubMed Web of Science ®Google Scholar
• Mohammadi, F., Ashrafi, M., Zandieh, Z., Najafi, M., Niknafs, B., Amjadi, F. S., & Haghighi, M. (2020). The effect of preincubation time and myo-inositol supplementation on the quality of mouse MII oocytes. Journal of Reproduction & Infertility, 21(4), 259–268. https://doi.org/10.18502/jri.v21i4.4330
   PubMedGoogle Scholar
• Mohammadi, F., Varanloo, N., Nasrabadi, M. H., Vatannejad, A., Amjadi, F., Masroor, M. J., Bajelan, L., Mehdizadeh, M., Aflatoonian, R., & Zandieh, Z. (2019). Supplementation of sperm freezing medium with myoinositol improve human sperm parameters and protects it against DNA fragmentation and apoptosis. Cell and Tissue Banking, 20(1), 77–86. https://doi.org/10.1007/s10561-018-9731-0
   PubMed Web of Science ®Google Scholar
• Montanino-Oliva, M., Buonomo, G., Carra, M., Lippa, A., & Lisi, F. (2020). Myo-inositol impact on sperm motility in vagina and evaluation of its effects on foetal development. European Review for Medical and Pharmacological Sciences, 24(5), 2704–2709 https://doi.org/10.26355/eurrev_202003_20540
   PubMed Web of Science ®Google Scholar
• Montanino-Oliva, M., Minutolo, E., Lippa, A., Iaconianni, P., & Vaiarelli, A. (2016). Effect of myoinositol and antioxidants on sperm quality in men with metabolic syndrome. International Journal of Endocrinology, 2016, 1674950. https://doi.org/10.1155/2016/1674950
   PubMed Web of Science ®Google Scholar
• Murgia, F., Corda, V., Serrenti, M., Usai, V., Santoru, M. L., Hurt, K. J., Passaretti, M., Monni, M. C., Atzori, L., & Monni, G. (2020). Seminal fluid metabolomic markers of oligozoospermic infertility in humans. Metabolites, 10(2), 64. https://doi.org/10.3390/metabo10020064
   PubMed Web of Science ®Google Scholar
• Nestler, J. E., & Unfer, V. (2015). Reflections on inositol(s) for PCOS therapy: Steps toward success. Gynecological Endocrinology, 31(7), 501–505. https://doi.org/10.3109/09513590.2015.1054802
   PubMed Web of Science ®Google Scholar
• Nordio, M., Basciani, S., & Camajani, E. (2019). The 40:1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: Comparison with other ratios. European Review for Medical and Pharmacological Sciences, 23(12), 5512–5521 https://doi.org/10.26355/eurrev_201906_18223
   PubMed Web of Science ®Google Scholar
• Nowicka-Bauer, K., & Nixon, B. (2020). Molecular changes induced by oxidative stress that impair human sperm motility. Antioxidants, 9(2), 134. https://doi.org/10.3390/antiox9020134
   Web of Science ®Google Scholar
• Pacchiarotti, A., Carlomagno, G., Antonini, G., & Pacchiarotti, A. (2016). Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome. Gynecological Endocrinology, 32(1), 69–73. https://doi.org/10.3109/09513590.2015.1101444
   PubMed Web of Science ®Google Scholar
• Paige, S. L., Osugi, T., Afanasiev, O. K., Pabon, L., Reinecke, H., & Murry, C. E. (2010). Endogenous Wnt/beta-catenin signaling is required for cardiac differentiation in human embryonic stem cells. PLoS One, 5(6), e11134. https://doi.org/10.1371/journal.pone.0011134
   PubMed Web of Science ®Google Scholar
• Pallotti, F., Cargnelutti, F., Senofonte, G., Carlini, T., Faja, F., Paoli, D., & Lombardo, F. (2019). In vitro effects of myo-inositol on normokinetic human semen samples with nonlinear motility. European Review for Medical and Pharmacological Sciences, 23(23), 10557–10563. https://doi.org/10.26355/eurrev_201912_19697
   PubMed Web of Science ®Google Scholar
• Palmieri, M., & da Siena, V. S. C. (2016). Myoinositol: From gametes to embryonic development. Current Trends in Clinical Embriology, 3(1), 19–29. https://doi.org/10.11138/cce/2016.3.1.019
   Google Scholar
• Palmieri, M., Papale, P., Della Ragione, A., Quaranta, G., Russo, G., & Russo, S. (2016). In vitro antioxidant treatment of semen samples in assisted reproductive technology: Effects of myo-inositol on nemaspermic parameters. International Journal of Endocrinology, 2016, 1–5. https://doi.org/10.1155/2016/2839041
   Web of Science ®Google Scholar
• Panner Selvam, M. K., Finelli, R., Agarwal, A., & Henkel, R. (2021). Evaluation of seminal oxidation-reduction potential in male infertility. Andrologia, 53(2), e13610. https://doi.org/10.1111/and.13610
   PubMed Web of Science ®Google Scholar
• Papaleo, E., Unfer, V., Baillargeon, J.-P., Fusi, F., Occhi, F., & De Santis, L. (2009). Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial. Fertility and Sterility, 91(5), 1750–1754. https://doi.org/10.1016/j.fertnstert.2008.01.088
   PubMed Web of Science ®Google Scholar
• Pesty, A., Avazeri, N., & Lefèvre, B. (1998). Nuclear calcium release by InsP3-receptor channels plays a role in meiosis reinitiation in the mouse oocyte. Cell Calcium, 24(4), 239–251. https://doi.org/10.1016/S0143-4160(98)90048-3
   PubMed Web of Science ®Google Scholar
• Poverini, R., Carlomagno, G., Lisi, R., Lisi, F., & Oliva, M. M. (2014). Improving IUI outcomes by adding myo-inositol to the semen preparation procedure. Fertility and Sterility, 102(3), e334. https://doi.org/10.1016/j.fertnstert.2014.07.1131
   Web of Science ®Google Scholar
• Prabhakar, P., Mahey, R., Gupta, M., Khadgawat, R., Kachhawa, G., Sharma, J. B., Vanamail, P., Kumari, R., & Bhatla, N. (2021). Impact of myoinositol with metformin and myoinositol alone in infertile PCOS women undergoing ovulation induction cycles – Randomized controlled trial. Gynecological Endocrinology, 37(4), 332–336. https://doi.org/10.1080/09513590.2020.1810657
   PubMed Web of Science ®Google Scholar
• Punt–van der Zalm, J., Hendriks, J., Westphal, J., Kremer, J., Teerenstra, S., & Wetzels, A. (2009). Toxicity testing of human assisted reproduction devices using the mouse embryo assay. Reproductive Biomedicine Online, 18(4), 529–535. https://doi.org/10.1016/S1472-6483(10)60130-7
   PubMed Web of Science ®Google Scholar
• Raffone, E., Rizzo, P., & Benedetto, V. (2010). Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women. Gynecological Endocrinology, 26(4), 275–280. https://doi.org/10.3109/09513590903366996
   PubMed Web of Science ®Google Scholar
• Revelli, A., Delle Piane, L., Casano, S., Molinari, E., Massobrio, M., & Rinaudo, P. (2009). Follicular fluid content and oocyte quality: From single biochemical markers to metabolomics. Reproductive Biology and Endocrinology, 7, 40. https://doi.org/10.1186/1477-7827-7-40
   PubMed Web of Science ®Google Scholar
• Rizzo, P., Raffone, E., & Benedetto, V. (2010). Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles. A prospective, clinical trial. European Review for Medical and Pharmacological Sciences, 14(6), 555–561. https://www.europeanreview.org/article/780
   PubMed Web of Science ®Google Scholar
• Roberts, D., Brown, J., Medley, N., & Dalziel, S. R. (2017). Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. The Cochrane Database of Systematic Reviews, 3(3), CD004454. https://doi.org/10.1002/14651858.CD004454.pub3
   PubMed Web of Science ®Google Scholar
• Rubino, P., Palini, S., Chigioni, S., Carlomagno, G., Quagliariello, A., De Stefani, S., Baglioni, A., & Bulletti, C. (2015). Improving fertilization rate in ICSI cycles by adding myoinositol to the semen preparation procedures: A prospective, bicentric, randomized trial on sibling oocytes. Journal of Assisted Reproduction and Genetics, 32(3), 387–394. https://doi.org/10.1007/s10815-014-0401-2
   PubMed Web of Science ®Google Scholar
• Sacchi, S., Marinaro, F., Tondelli, D., Lui, J., Xella, S., Marsella, T., Tagliasacchi, D., Argento, C., Tirelli, A., Giulini, S., & La Marca, A. (2016). Modulation of gonadotrophin induced steroidogenic enzymes in granulosa cells by d-chiroinositol. Reproductive Biology and Endocrinology, 14(1), 52. https://doi.org/10.1186/s12958-016-0189-2
   PubMedGoogle Scholar
• Saleh, R., Assaf, H., Abd El Maged, W. M., Elsuity, M., & Fawzy, M. (2018). Increased cryo-survival rate in ejaculated human sperm from infertile men following pre-freeze in vitro myo-inositol supplementation. Clinical and Experimental Reproductive Medicine, 45(4), 177–182. https://doi.org/10.5653/cerm.2018.45.4.177
   PubMedGoogle Scholar
• Santamaria, A., Giordano, D., Corrado, F., Pintaudi, B., Interdonato, M., Vieste, G. D., Benedetto, A. D., & D’Anna, R. (2012). One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome. Climacteric, 15(5), 490–495. https://doi.org/10.3109/13697137.2011.631063
   PubMed Web of Science ®Google Scholar
• Santoro, M., Aquila, S., & Russo, G. (2021). Sperm performance in oligoasthenoteratozoospermic patients is induced by a nutraceuticals mix, containing mainly myo-inositol. Systems Biology in Reproductive Medicine, 67(1), 50–63. https://doi.org/10.1080/19396368.2020.1826067
   PubMed Web of Science ®Google Scholar
• Scarselli, F., Lobascio, A. M., Terribile, M., Casciani, V., Greco, P., Franco, G., Minasi, M. G., & Greco, E. (2016). Analysis of MYO-Inositol effect on spermatozoa motility, in hyper viscous ejaculates and in patients with grades II and III varicocele. Archivio Italiano di Urologia, Andrologia, 88(4), 279–283. https://doi.org/10.4081/aiua.2016.4.279
   Google Scholar
• Schillaci, R., Mangione, D., Lo Monte, G., & Vassiliadis, A. (2012). Inositol supplementation and IVF outcome: Preliminary data. Italian Journal of Gynaecology and Obstetrics, 24(1), 38–44.
   Google Scholar
• Stachecki, J. J., & Armant, D. R. (1996). Transient release of calcium from inositol 1,4,5-trisphosphate-specific stores regulates mouse preimplantation development. Development, 122(8), 2485–2496. https://doi.org/10.1242/dev.122.8.2485
   PubMed Web of Science ®Google Scholar
• Stambolic, V., Ruel, L., & Woodgett, J. R. (1996). Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Current Biology, 6(12), 1664–1669. https://doi.org/10.1016/S0960-9822(02)70790-2
   PubMed Web of Science ®Google Scholar
• Thomas, R. M., Nechamen, C. A., Mazurkiewicz, J. E., Ulloa-Aguirre, A., & Dias, J. A. (2011). The adapter protein APPL1 links FSH receptor to inositol 1,4,5-trisphosphate production and is implicated in intracellular Ca(2+) mobilization . Endocrinology, 152(4), 1691–1701. https://doi.org/10.1210/en.2010-1353
   PubMed Web of Science ®Google Scholar
• Unfer, V., Carlomagno, G., Papaleo, E., Vailati, S., Candiani, M., & Baillargeon, J.-P. (2014). Hyperinsulinemia alters myoinositol to d-chiroinositol ratio in the follicular fluid of patients with PCOS. Reproductive Sciences, 21(7), 854–858. https://doi.org/10.1177/1933719113518985
   PubMed Web of Science ®Google Scholar
• Van der Auwera, I., & D'Hooghe, T. (2001). Superovulation of female mice delays embryonic and fetal development. Human Reproduction, 16(6), 1237–1243. https://doi.org/10.1093/humrep/16.6.1237
   PubMed Web of Science ®Google Scholar
• Vartanyan, E., Tsaturova, K., Devyatova, E., Mikhaylyukova, A., Levin, V., Petuhova, N., Markin, A., & Steptsova, E. (2017). Improvement in quality of oocytes in polycystic ovarian syndrome in programs of in vitro fertilization. Gynecological Endocrinology, 33(sup1), 8–11. https://doi.org/10.1080/09513590.2017.1399699
   PubMed Web of Science ®Google Scholar
• Vazquez-Levin, M. H., & Verón, G. L. (2020). Myo-inositol in health and disease: Its impact on semen parameters and male fertility. Andrology, 8(2), 277–298. https://doi.org/10.1111/andr.12718
   PubMed Web of Science ®Google Scholar
• Voglmayr, J. K., & White, I. G. (1971). Synthesis and metabolism of myoinositol in testicular and ejaculated spermatozoa of the ram. Journal of Reproduction and Fertility, 24(1), 29–37. https://doi.org/10.1530/jrf.0.0240029
   PubMedGoogle Scholar
• Warner, S., Conlon, F., & Kane, M. (2003). Inositol transport in preimplantation rabbit embryos: Effects of embryo stage, sodium, osmolality and metabolic inhibitors. Reproduction, 125(4), 479–493. https://doi.org/10.1530/rep.0.1250479
   PubMed Web of Science ®Google Scholar
• Wdowiak, A. (2016). Myoinositol improves embryo development in PCOS patients undergoing ICSI. International Journal of Endocrinology, 2016, 6273298. https://doi.org/10.1155/2016/6273298
   PubMed Web of Science ®Google Scholar
• Wiener-Megnazi, Z., Vardi, L., Lissak, A., Shnizer, S., Reznick, A. Z., Ishai, D., Lahav-Baratz, S., Shiloh, H., Koifman, M., & Dirnfeld, M. (2004). Oxidative stress indices in follicular fluid as measured by the thermochemiluminescence assay correlate with outcome parameters in in vitro fertilization. Fertility and Sterility, 82(Suppl 3), 1171–1176. https://doi.org/10.1016/j.fertnstert.2004.06.013
   PubMedGoogle Scholar
• Willert, K., & Jones, K. A. (2006). Wnt signaling: Is the party in the nucleus? Genes & Development, 20(11), 1394–1404. https://doi.org/10.1101/gad.1424006
   PubMed Web of Science ®Google Scholar
• Zheng, X., Lin, D., Zhang, Y., Lin, Y., Song, J., Li, S., & Sun, Y. (2017). Inositol supplement improves clinical pregnancy rate in infertile women undergoing ovulation induction for ICSI or IVF-ET. Medicine, 96(49), e8842. https://doi.org/10.1097/MD.0000000000008842
   PubMed Web of Science ®Google Scholar